APOPKA, Fla.--(BUSINESS WIRE)--April 22, 2004-- Agreement Signed With Yangling Daiying Biological Engineering Co., Ltd.
Sun City Industries, Inc. (OTCBB: SCII) has entered into a Reorganization Agreement with Yangling Daiying Biological Engineering Co., Ltd., a corporation organized under the laws of the People's Republic of China. Daiying has developed the world's very first Hepatitis C virus (HCV) culture that retains biological activity in vitro. The Reorganization Agreement is conditional upon the signing of a consulting agreement, warrant agreement and the completion of various schedules to be part of the Reorganization Agreement. A closing date has not yet been set but the parties are striving to close in April 2004. Sun City will be filing an 8K to satisfy its reporting requirements under Regulation FD and the Exchange Act of 1934 as amended. The Reorganization Agreement will be provided as an exhibit to the 8K.
Statements in this press release that relate to Sun City Industries' future plans, objectives, expectations, performance, events and the like are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the Securities Exchange Act of 1934. Future events, risks and uncertainties, individually or in the aggregate, could cause actual results to differ materially from those expressed or implied in these statements. Those factors could include changes in economic conditions that may change demand for the Company's products and services and other factors discussed in the "forward-looking information" section and the "risk factor" section of the management's discussion and analysis included in the Company's report on Form 10-K for the year ended December 31, 2003 filed with the Securities and Exchange Commission. This release is comprised of interrelated information that must be interpreted in the context of all of the information provided and care should be exercised not to consider portions of this release out of context. Sun City Industries uses paid services of investor relations organizations to promote the Company to the investment community. Investments in any company should be considered speculative and prior to acquisition, should be thoroughly researched. Sun City Industries does not intend to update these forward-looking statements prior to announcement of quarterly or annual results.
Contacts
Sun City Industries, Inc. Michael F. Manion, 407-880-2213
